HRP20190026T1 - Testovi za određivanje prisutnosti ili količine protutijela protiv lijeka - Google Patents
Testovi za određivanje prisutnosti ili količine protutijela protiv lijekaInfo
- Publication number
- HRP20190026T1 HRP20190026T1 HRP20190026TT HRP20190026T HRP20190026T1 HR P20190026 T1 HRP20190026 T1 HR P20190026T1 HR P20190026T T HRP20190026T T HR P20190026TT HR P20190026 T HRP20190026 T HR P20190026T HR P20190026 T1 HRP20190026 T1 HR P20190026T1
- Authority
- HR
- Croatia
- Prior art keywords
- tests
- antibodies against
- medicinal product
- medicinal
- product
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461938556P | 2014-02-11 | 2014-02-11 | |
| EP15710304.5A EP3105592B1 (en) | 2014-02-11 | 2015-02-11 | Assays for detecting the presence or amount of an anti-drug antibody |
| PCT/US2015/015442 WO2015123315A1 (en) | 2014-02-11 | 2015-02-11 | Assays for detecting the presence or amount of an anti-drug antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20190026T1 true HRP20190026T1 (hr) | 2019-02-22 |
Family
ID=52684652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20190026TT HRP20190026T1 (hr) | 2014-02-11 | 2015-02-11 | Testovi za određivanje prisutnosti ili količine protutijela protiv lijeka |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US9759732B2 (hr) |
| EP (5) | EP3105592B1 (hr) |
| CN (1) | CN106164670B (hr) |
| AU (2) | AU2015217261B2 (hr) |
| CA (1) | CA2939080A1 (hr) |
| CY (1) | CY1121341T1 (hr) |
| DK (1) | DK3105592T3 (hr) |
| ES (1) | ES2705403T3 (hr) |
| HR (1) | HRP20190026T1 (hr) |
| HU (1) | HUE041669T2 (hr) |
| LT (1) | LT3105592T (hr) |
| MX (2) | MX374652B (hr) |
| PL (1) | PL3105592T3 (hr) |
| PT (1) | PT3105592T (hr) |
| RS (1) | RS58212B1 (hr) |
| SG (2) | SG11201606291VA (hr) |
| SI (1) | SI3105592T1 (hr) |
| TR (1) | TR201900160T4 (hr) |
| WO (1) | WO2015123315A1 (hr) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015123315A1 (en) | 2014-02-11 | 2015-08-20 | Genzyme Corporation | Assays for detecting the presence or amount of an anti-drug antibody |
| EP2982987A1 (en) * | 2014-08-08 | 2016-02-10 | Proteomika, S.L. | Lateral flow immunoassays for the detection of antibodies against biological drugs |
| US9927443B2 (en) * | 2015-04-10 | 2018-03-27 | Conquerab Inc. | Risk assessment for therapeutic drugs |
| CA3000929C (en) * | 2015-10-15 | 2023-09-19 | Biocon Limited | Method for detecting neutralizing antibodies against recombinant human insulin in human serum |
| JP6889160B2 (ja) | 2015-12-16 | 2021-06-18 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ３段階酸解離酵素結合免疫吸着（ｔａｄｅｌｉｓ）アッセイ法 |
| US9903866B2 (en) | 2016-04-05 | 2018-02-27 | Conquerab Inc. | Portable devices for detection of antibodies against therapeutic drugs |
| EP3239711B1 (en) * | 2016-04-27 | 2019-12-25 | JIMRO Co., Ltd. | Method for measuring anti-drug antibody |
| MX2019004691A (es) | 2016-10-20 | 2019-12-09 | I Mab Biopharma Us Ltd | Anticuerpos monoclonales cd47 novedosos y sus usos. |
| CN110997727B (zh) * | 2017-08-08 | 2025-03-18 | 豪夫迈·罗氏有限公司 | 用于确定微型猪样品中抗药物抗体的方法 |
| ES3012463T3 (en) | 2017-11-29 | 2025-04-09 | Hoffmann La Roche | Target interference suppressed anti-drug antibody assay |
| CN109358192B (zh) * | 2018-02-08 | 2020-05-12 | 中国科学院上海药物研究所 | 一种去除抗药抗体检测样品中游离药物的装置和方法、该装置的制备方法及应用 |
| IL277890B2 (en) * | 2018-04-11 | 2024-03-01 | Regeneron Pharma | Methods for quantification of IL-33 |
| BR112020022912A2 (pt) * | 2018-07-10 | 2021-02-23 | Regeneron Pharmaceuticals, Inc. | métodos para mitigar a interferência de alvo de fármaco em um imunoensaio de anticorpo antifármaco (ada) |
| WO2020028764A1 (en) * | 2018-08-03 | 2020-02-06 | Bristol-Myers Squibb Company | Methods for detecting anti-drug antibodies |
| EP3956665A1 (en) * | 2019-04-16 | 2022-02-23 | Laboratory Corporation of America Holdings | Methods and systems for detecting antibodies by surface plasmon resonance |
| KR102695013B1 (ko) | 2019-04-24 | 2024-08-13 | 삼성전자주식회사 | 펠리클 조립체의 제조 방법 및 포토마스크 조립체의 제조 방법 |
| CN111982615A (zh) * | 2019-05-23 | 2020-11-24 | 百奥泰生物制药股份有限公司 | 一种用于解离药物/ada复合物的解离液及其应用 |
| CN112285351A (zh) * | 2019-07-22 | 2021-01-29 | 上海益诺思生物技术股份有限公司 | 一种抗IgE单抗的ELISA检测方法 |
| CA3148161A1 (en) * | 2019-09-05 | 2021-03-11 | Adverum Biotechnologies | Anti-drug antibody assay |
| CN111171141A (zh) * | 2020-01-20 | 2020-05-19 | 苏州药明康德新药开发有限公司 | 聚乙二醇在临床前安全性评价中的应用 |
| CN111024958B (zh) * | 2020-03-11 | 2020-06-23 | 同昕生物技术（北京）有限公司 | 用于检测单抗药物和抗单抗药物抗体的试剂及其应用 |
| CA3180569A1 (en) * | 2020-05-01 | 2021-11-04 | Regeneron Pharmaceuticals, Inc. | Neutralizing antibody assay for therapeutic proteins |
| JP7478040B2 (ja) * | 2020-06-25 | 2024-05-02 | シスメックス株式会社 | Ａβペプチドの測定方法及びその方法に用いられる試薬組成物 |
| WO2022078466A1 (en) * | 2020-10-14 | 2022-04-21 | I-Mab Biopharma Co., Ltd. | Methods for mitigating interference by therapeutic anti-cd47 antibodies in pre-transfusion assays |
| JP7062803B1 (ja) | 2021-03-31 | 2022-05-06 | 積水メディカル株式会社 | 抗薬物抗体測定方法 |
| MX2024007473A (es) | 2021-12-14 | 2024-09-10 | Cdr Life Ag | Activador del linfocito t dirigido al mhc doble. |
| CN114047343B (zh) * | 2022-01-13 | 2022-05-31 | 美迪西普亚医药科技(上海)有限公司 | 双耐受型抗IgE单抗药物的免疫原性分析试剂盒及其使用方法和应用 |
| AU2023336565A1 (en) | 2022-09-09 | 2025-02-20 | Bayer Aktiengesellschaft | Medical use of ccr8 antibodies and dosing schedule |
| WO2024056758A1 (en) | 2022-09-14 | 2024-03-21 | Cdr-Life Ag | Mage-a4 peptide dual t cell engagers |
| CN120239821A (zh) * | 2022-09-23 | 2025-07-01 | 默沙东有限责任公司 | 中和抗体测定方法 |
| CN115561355B (zh) * | 2022-09-26 | 2024-04-30 | 重庆迪纳利医药科技有限责任公司 | 羧肽酶g2的中和抗体检测方法以及基于lc-ms/ms的检测系统 |
| CN116699147A (zh) * | 2023-08-04 | 2023-09-05 | 军科正源（北京）药物研究有限责任公司 | 检测总IgE含量的方法以及相关试剂盒 |
| CN117849327A (zh) * | 2024-03-06 | 2024-04-09 | 军科正源（北京）药物研究有限责任公司 | 用于检测苏金单抗抗药性抗体的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990006515A1 (en) * | 1988-12-09 | 1990-06-14 | Centocor, Inc. | Anti-idiotopic immunometric assay |
| US5187065A (en) * | 1989-12-22 | 1993-02-16 | Schutzer Steven E | Method and materials for detecting lyme disease |
| EP1996943B1 (en) * | 2006-03-09 | 2014-06-25 | F.Hoffmann-La Roche Ag | Anti-drug antibody assay |
| CA2686206A1 (en) * | 2007-05-07 | 2008-11-13 | Wyeth | Elimination of interference in immunoassays caused by anti-carbohydrate antibodies |
| WO2009091240A1 (en) * | 2008-01-15 | 2009-07-23 | Stichting Sanquin Bloedvoorziening | Method and kits for detecting antibodies against therapeutic antibodies |
| JP2010078374A (ja) | 2008-09-24 | 2010-04-08 | Olympus Corp | 抗赤血球抗体の検出方法 |
| US7799532B2 (en) * | 2008-11-12 | 2010-09-21 | Hemopet | Detection and measurement of thyroid hormone autoantibodies |
| CA2827609A1 (en) | 2011-02-17 | 2012-11-15 | Nestec S.A. | Assays for detecting autoantibodies to anti-tnf.alpha. drugs |
| KR102084805B1 (ko) * | 2012-03-08 | 2020-03-04 | 에프. 호프만-라 로슈 아게 | 순환 면역 복합체의 특성화를 위한 다중 크로마토그래피-면역분석 방법 |
| CN105378480B (zh) * | 2013-07-04 | 2018-06-12 | 豪夫迈·罗氏有限公司 | 检测血清样品中抗药物抗体的干扰抑制性免疫测定 |
| WO2015123315A1 (en) | 2014-02-11 | 2015-08-20 | Genzyme Corporation | Assays for detecting the presence or amount of an anti-drug antibody |
-
2015
- 2015-02-11 WO PCT/US2015/015442 patent/WO2015123315A1/en active Application Filing
- 2015-02-11 CA CA2939080A patent/CA2939080A1/en not_active Abandoned
- 2015-02-11 AU AU2015217261A patent/AU2015217261B2/en active Active
- 2015-02-11 EP EP15710304.5A patent/EP3105592B1/en active Active
- 2015-02-11 SI SI201530551T patent/SI3105592T1/sl unknown
- 2015-02-11 TR TR2019/00160T patent/TR201900160T4/tr unknown
- 2015-02-11 EP EP25163892.0A patent/EP4582812A2/en active Pending
- 2015-02-11 PL PL15710304T patent/PL3105592T3/pl unknown
- 2015-02-11 ES ES15710304T patent/ES2705403T3/es active Active
- 2015-02-11 DK DK15710304.5T patent/DK3105592T3/en active
- 2015-02-11 SG SG11201606291VA patent/SG11201606291VA/en unknown
- 2015-02-11 EP EP18188141.8A patent/EP3422001B1/en active Active
- 2015-02-11 EP EP20154994.6A patent/EP3667321B1/en active Active
- 2015-02-11 EP EP22175920.2A patent/EP4137816B1/en active Active
- 2015-02-11 CN CN201580018956.7A patent/CN106164670B/zh active Active
- 2015-02-11 RS RS20190027A patent/RS58212B1/sr unknown
- 2015-02-11 SG SG10201906750XA patent/SG10201906750XA/en unknown
- 2015-02-11 HR HRP20190026TT patent/HRP20190026T1/hr unknown
- 2015-02-11 US US14/619,422 patent/US9759732B2/en active Active
- 2015-02-11 LT LTEP15710304.5T patent/LT3105592T/lt unknown
- 2015-02-11 PT PT15710304T patent/PT3105592T/pt unknown
- 2015-02-11 HU HUE15710304A patent/HUE041669T2/hu unknown
- 2015-02-11 MX MX2016010413A patent/MX374652B/es active IP Right Grant
-
2016
- 2016-08-10 MX MX2020009021A patent/MX2020009021A/es unknown
-
2017
- 2017-08-08 US US15/671,663 patent/US11215623B2/en active Active
-
2019
- 2019-01-14 CY CY20191100037T patent/CY1121341T1/el unknown
-
2020
- 2020-11-04 AU AU2020264316A patent/AU2020264316A1/en not_active Abandoned
-
2021
- 2021-11-23 US US17/534,012 patent/US11927596B2/en active Active
-
2024
- 2024-01-31 US US18/428,535 patent/US20240288454A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20190026T1 (hr) | Testovi za određivanje prisutnosti ili količine protutijela protiv lijeka | |
| IL251970B (en) | Anti-cd79b antibodies and methods of use | |
| IL251821A0 (en) | Cannabis extracts and methods of preparing and using same | |
| KR102355950B9 (ko) | Tigit에 대한 항체 | |
| HUE055331T2 (hu) | Pro/látens-miosztatin elleni ellenanyagok és alkalmazásuk | |
| HUE055465T2 (hu) | PD-L1 ellenes humán antitestek | |
| PL3353210T3 (pl) | Przeciwciała anty-TIGIT i sposoby stosowania | |
| IL248519A0 (en) | Bioceramic compositions and biomodulatory uses thereof | |
| PL3148579T3 (pl) | Przeciwciała anty-gitr i sposoby ich zastosowania | |
| MA47472A (fr) | Anticorps | |
| SI3237001T1 (sl) | Farmacevtski izdelki in obstojni tekoči sestavki protiteles il-17 | |
| MA45004A (fr) | Anticorps spécifiques anti-wt1-hla | |
| IL247262B (en) | Cannabinoid compositions and uses | |
| HUE052771T2 (hu) | C10orf54 elleni antitestek és alkalmazásuk | |
| BR112016026879A2 (pt) | Composição farmacêutica líquida | |
| DK3089741T3 (da) | Farmaceutiske sammensætninger omfattende azd9291 | |
| CL2016002569A1 (es) | Anticuerpos, composiciones farmacéuticas y usos de los mismos | |
| EA201691610A8 (ru) | Анти-jagged1 антитела и способы применения | |
| PT3218005T (pt) | Compostos que interagem com glicano e métodos de uso | |
| PT3223827T (pt) | Composição de fibras alimentares | |
| DK3532029T3 (da) | Flydende farmaceutisk sammensætning | |
| HUE050779T2 (hu) | Folyékony gyógyszerészeti készítmény | |
| BR112016024803A2 (pt) | suportes abrasivos e métodos de sua formação | |
| LT3212237T (lt) | Metotreksato vaistinė forma | |
| FI20145128L (fi) | Varhainen akuutin kaatumisriskin havaitseminen |